{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:21:17Z","timestamp":1794986477609,"version":"4.9.1"},"reference-count":34,"publisher":"Informa UK Limited","issue":"5-6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunoassay and Immunochemistry"],"published-print":{"date-parts":[[2026,11,2]]},"DOI":"10.1080\/15321819.2026.2709873","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:01:57Z","timestamp":1785571317000},"page":"383-402","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Co-overexpression of CDC27 and PD-L1 defines an ultra\u2013high-risk subgroup of acute myeloid leukemia in an Egyptian cohort"],"prefix":"10.1080","volume":"47","author":[{"given":"Amira Zaki","family":"Badawy","sequence":"first","affiliation":[{"name":"Menoufia University","place":["Shebeen El-kom, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alshimaa Rabie Soliman","family":"Elkholy","sequence":"additional","affiliation":[{"name":"Menoufia University","place":["Shebeen El-kom, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly Mohamed","family":"Elkholy","sequence":"additional","affiliation":[{"name":"Menoufia University","place":["Shebeen El-kom, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa Elsayed Ramadan","family":"Genena","sequence":"additional","affiliation":[{"name":"Menoufia University, Shebeen El-Kom","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Helmy","family":"Hebesh","sequence":"additional","affiliation":[{"name":"Menoufia University","place":["Shebeen El-kom, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Hassan","family":"El-sheity","sequence":"additional","affiliation":[{"name":"Menoufia University","place":["Shebeen El-kom, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2602"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1988"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-206672"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01710"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00488"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-172007"},{"issue":"23","key":"e_1_3_4_9_1","first-page":"5638","article-title":"Persistence of High LDH in AML Patients is Associated with Adverse Prognosis","volume":"116","author":"Chen Y.","year":"2010","unstructured":"Chen, Y.; Cortes, J.; Estrov, Z.; Faderl, S.; Ravandi, F.; Konopleva, M. Persistence of High LDH in AML Patients is Associated with Adverse Prognosis. Cancer 2010, 116(23), 5638\u20135642.","journal-title":"Cancer"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2351-x"},{"issue":"9","key":"e_1_3_4_11_1","first-page":"829","article-title":"Optimizing Survival Outcomes with Post-Remission Therapy in Acute Myeloid Leukemia","volume":"90","author":"Medeiros B. C.","year":"2015","unstructured":"Medeiros, B. C.; Chan, S. M.; Daver, N. G.; Jonas, B. A.; Pollyea, D. A. Optimizing Survival Outcomes with Post-Remission Therapy in Acute Myeloid Leukemia. Am. J. Hematol. 2015, 90(9), 829\u2013838.","journal-title":"Am. J. Hematol."},{"issue":"2","key":"e_1_3_4_12_1","first-page":"64","article-title":"Clinical Outcome of Adult Acute Myeloid Leukemia Patients: A Single-Center Experience in Egypt","volume":"10","author":"Mansour A.","year":"2017","unstructured":"Mansour, A.; El-Sissy, A.; Eissa, D. G.; Khorshid, O.; Elghannam, D.; Abdel-Mabood, S. Clinical Outcome of Adult Acute Myeloid Leukemia Patients: A Single-Center Experience in Egypt. Hematol Oncol. STEM Cell. Ther. 2017, 10(2), 64\u201369.","journal-title":"Hematol Oncol. STEM Cell. Ther."},{"issue":"8","key":"e_1_3_4_13_1","first-page":"818","article-title":"Prognostic Significance of CD34 Expression in Acute Myeloid Leukemia Patients Undergoing Chemotherapy and Allogeneic Stem Cell Transplantation","volume":"39","author":"Wang Y.","year":"2015","unstructured":"Wang, Y.; Wu, D. P.; Liu, Q. F.; Qin, Y. Z.; Wang, J. B.; Xu, L. P. Prognostic Significance of CD34 Expression in Acute Myeloid Leukemia Patients Undergoing Chemotherapy and Allogeneic Stem Cell Transplantation. Leuk. Res. 2015, 39(8), 818\u2013823.","journal-title":"Leuk. Res."},{"issue":"7","key":"e_1_3_4_14_1","first-page":"1234","article-title":"High Expression of CD34 in Acute Myeloid Leukemia is Correlated with Poor Prognosis","volume":"25","author":"Campos L.","year":"2011","unstructured":"Campos, L.; Roux, J. P.; Roubi, N.; Vasselon, C.; Archimbaud, E.; Magaud, J. P. High Expression of CD34 in Acute Myeloid Leukemia is Correlated with Poor Prognosis. Leukemia 2011, 25(7), 1234\u20131241.","journal-title":"Leukemia"},{"issue":"3","key":"e_1_3_4_15_1","first-page":"191","article-title":"Evaluation and Surgical Treatment of Solitary Thyroid Nodules","volume":"72","author":"Adwok J. A.","year":"1995","unstructured":"Adwok, J. A. Evaluation and Surgical Treatment of Solitary Thyroid Nodules. East Afr. Med. J. 1995, 72(3), 191\u2013193.","journal-title":"East Afr. Med. J."},{"issue":"2","key":"e_1_3_4_16_1","first-page":"321","article-title":"Clinical Outcome of Adult Acute Myeloid Leukemia Patients: A Single Center Experience from Egypt","volume":"18","author":"Mansour A.","year":"2017","unstructured":"Mansour, A.; El-Banna, H.; El-Gammal, M.; Abouzeid, T.; Kamel, M.; Eissa, D. Clinical Outcome of Adult Acute Myeloid Leukemia Patients: A Single Center Experience from Egypt. Asian Pac. J. Cancer Prev. 2017, 18(2), 321\u2013326.","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"e_1_3_4_17_1","first-page":"141","article-title":"Outcome of adult acute myeloid leukemia: experience from a tertiary care center in Egypt","volume":"27","author":"Eissa D. S.","year":"2015","unstructured":"Eissa, D. S.; Youssry, I.; El-Ashwah, S.; Kamal, N.; Ibrahim, L.; Hamed, N. Outcome of adult acute myeloid leukemia: experience from a tertiary care center in Egypt. J Egypt Natl Canc Inst. 2015, 27(3), 141\u2013147.","journal-title":"J Egypt Natl Canc Inst."},{"issue":"22","key":"e_1_3_4_18_1","first-page":"e15822","article-title":"Survival and Prognostic Factors in Acute Myeloid Leukemia Patients Treated in a Romanian Hematology Center","volume":"98","author":"Popa A.","year":"2019","unstructured":"Popa, A.; Ciubean, A. D.; Fetica, B.; Zdrenghea, M.; Zdrenghea, D. Survival and Prognostic Factors in Acute Myeloid Leukemia Patients Treated in a Romanian Hematology Center. Med. (Baltim.) 2019, 98(22), e15822.","journal-title":"Med. (Baltim.)"},{"issue":"3","key":"e_1_3_4_19_1","first-page":"390","article-title":"Role of CDC27 in Cell Cycle Regulation and Carcinogenesis","volume":"10","author":"Chang D. Z.","year":"2012","unstructured":"Chang, D. Z.; Ma, Y.; Ji, B.; Wang, H.; Wang, J.; Li, D. Role of CDC27 in Cell Cycle Regulation and Carcinogenesis. Mol. Cancer Res. 2012, 10(3), 390\u2013400.","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"e_1_3_4_20_1","first-page":"6469","article-title":"CDC27 Promotes Tumor Progression and Predicts Poor Prognosis in Human Cancers","volume":"15","author":"Liu Y.","year":"2018","unstructured":"Liu, Y.; Zhang, H.; Kong, C.; Wang, C. CDC27 Promotes Tumor Progression and Predicts Poor Prognosis in Human Cancers. Oncol. Lett. 2018, 15(5), 6469\u20136475.","journal-title":"Oncol. Lett."},{"key":"e_1_3_4_21_1","first-page":"e2287","article-title":"High Expression of CDC27 Indicates Poor Prognosis in Colorectal Cancer","volume":"4","author":"Wang Z.","year":"2016","unstructured":"Wang, Z.; Gao, D.; Zhang, H.; Liu, C.; Xu, Y.; Wang, W. High Expression of CDC27 Indicates Poor Prognosis in Colorectal Cancer. PeerJ 2016, 4, e2287.","journal-title":"PeerJ"},{"issue":"10","key":"e_1_3_4_22_1","first-page":"3089","article-title":"Nuclear Expression of CDC27 as a Prognostic Marker in Rectal Adenocarcinoma Treated with Adjuvant Chemotherapy","volume":"13","author":"Lin C. C.","year":"2022","unstructured":"Lin, C. C.; Wu, M. J.; Tsai, Y. P.; Yang, M. H. Nuclear Expression of CDC27 as a Prognostic Marker in Rectal Adenocarcinoma Treated with Adjuvant Chemotherapy. J Cancer 2022, 13(10), 3089\u20133099.","journal-title":"J Cancer"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01624-x"},{"issue":"22","key":"e_1_3_4_24_1","first-page":"10245","article-title":"Downregulation of APC\/C Subunit CDC27 Contributes to Cyclin D1 Overexpression in Breast Cancer Cells","volume":"107","author":"Li Y.","year":"2010","unstructured":"Li, Y.; Wang, Y.; Liu, J.; Fan, Z. Downregulation of APC\/C Subunit CDC27 Contributes to Cyclin D1 Overexpression in Breast Cancer Cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(22), 10245\u201310250.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"e_1_3_4_25_1","first-page":"511","article-title":"CDC27 Gene Expression Patterns as a Potential Biomarker in Acute Leukemia","volume":"25","author":"Hosseini S. A.","year":"2024","unstructured":"Hosseini, S. A.; Pouryasin, M.; Sadeghi, M.; Abdi, M.; Sadeghi, A. CDC27 Gene Expression Patterns as a Potential Biomarker in Acute Leukemia. Asian Pac. J. Cancer Prev. 2024, 25(2), 511\u2013516.","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"e_1_3_4_26_1","first-page":"697","article-title":"Prognostic significance of PD-L1 expression in acute myeloid leukemia","volume":"68","author":"Chen Y.","year":"2019","unstructured":"Chen, Y.; Zhang, H.; Li, S. Prognostic significance of PD-L1 expression in acute myeloid leukemia. Cancer Immunol. Immunother. 2019, 68(5), 697\u2013707.","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"e_1_3_4_27_1","first-page":"15391","article-title":"PD-L1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia","volume":"8","author":"Zhang W.","year":"2017","unstructured":"Zhang, W.; Yang, H.; Wang, Y. PD-L1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia. Oncotarget 2017, 8(9), 15391\u201315400.","journal-title":"Oncotarget"},{"issue":"13","key":"e_1_3_4_28_1","first-page":"1144","article-title":"Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed\/Refractory AML: A Phase II Study","volume":"134","author":"Daver N.","year":"2019","unstructured":"Daver, N.; Basu, S.; Garcia-Manero, G. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed\/Refractory AML: A Phase II Study. Blood 2019, 134(13), 1144\u20131153.","journal-title":"Blood"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S105862"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09744-7"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01860-9"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.004818"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00853-x"},{"issue":"4","key":"e_1_3_4_34_1","first-page":"103196","article-title":"Programmed Cell Death Ligand-1 Expression Level and Its Effects on Prognosis in Acute Myeloid Leukemia","volume":"60","author":"Geduk A.","year":"2021","unstructured":"Geduk, A.; Yilmaz, M.; Celen, M. K. Programmed Cell Death Ligand-1 Expression Level and Its Effects on Prognosis in Acute Myeloid Leukemia. TransfusApher Sci. 2021, 60(4), 103196.","journal-title":"TransfusApher Sci."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2025.100514"}],"container-title":["Journal of Immunoassay and Immunochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15321819.2026.2709873","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/15321819.2026.2709873","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15321819.2026.2709873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:06:48Z","timestamp":1794985608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15321819.2026.2709873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":34,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2026,11,2]]}},"alternative-id":["10.1080\/15321819.2026.2709873"],"URL":"https:\/\/doi.org\/10.1080\/15321819.2026.2709873","relation":{},"ISSN":["1532-1819","1532-4230"],"issn-type":[{"value":"1532-1819","type":"print"},{"value":"1532-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ljii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ljii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}